WEAU | Eau Claire, Wisconsin | News, Weather, & Sports

FDA panel narrowly backs DNA colon cancer test

By: AP Email
By: AP Email

WASHINGTON (AP) -- A panel of Food and Drug Administration advisers has narrowly backed an experimental blood test that uses patients' DNA to help screen for colon cancer.

The FDA's genetic experts voted 5-4, with one abstention, that the benefits of Epigenomics' test outweigh the risks. The vote amounts to a recommendation for approval of the company's Epi proColon kit. The FDA is not required to follow the panel's recommendation.

Doctors have long used stool tests to look for hidden blood that can be an early warning of cancer. Epigenomics' test is part of a new wave of diagnostics that detect genetic markers associated with cancerous tumors.

FDA scientists said in their review earlier this week that Epi proColon did not meet all of its accuracy goals in testing against older, stool-based technology.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
WEAU 13 NEWS 1907 S. Hastings Way Eau Claire, WI 54701 By Phone: Main Number (715) 835-1313 and (715) 832-3474. Tip Line (715) 839-WEAU - (715) 839-9328 Sports Line (715) 852-1537
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 252533571 - weau.com/a?a=252533571